The natural history of antibody responses to Cryptosporidium parasites in men at high risk of HIV infection

Journal of Infectious Diseases

Volumn 194, Issue 10, 2006, Pages 1428-1437

  Sandhu, Sukhminder K ^a,b,c,d   Priest, Jeffrey W ^a   Lammie, Patrick J ^a   Hubbard, Alan ^c   Colford Jr , John M ^c   Eisenberg, Joseph N S ^c,e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; RECOMBINANT ANTIGEN; TYLOXAPOL;

ADULT; ANTIBODY RESPONSE; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DISEASE SEVERITY; FOLLOW UP; HALF LIFE TIME; HIGH RISK POPULATION; HOST PARASITE INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIBODIES, PROTOZOAN; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 33750699349     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/508194     Document Type: Article

References (33)

1. Casemore DP. Epidemiological aspects of human cryptosporidiosis. Epidemiol Infect 1990; 104:1-28.
2. Meinhardt PL, Casemore DP, Miller KB. Epidemiologic aspects of human cryptosporidiosis and the role of waterborne transmission. Epidemiol Rev 1996; 18:118-36.
3. Guerrant RL. Cryptosporidiosis: an emerging, highly infectious threat. Emerg Infect Dis 1997; 3:51-7.
4. Dillingham RA, Lima AA, Guerrant RL. Cryptosporidiosis: epidemiology and impact. Microbes Infect 2002; 4:1059-66.
5. Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev 2002; 15:145-54.
6. Certad G, Arenas-Pinto A, Pocaterra L, et al. Cryptosporidiosis in HIV-infected Venezuelan adults is strongly associated with acute or chronic diarrhea. Am J Trop Med Hyg 2005; 73:54-7.
7. Pozio E, Rezza G, Boschini A, et al. Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users. J Infect Dis 1997; 176:969-75.
8. Fayer R, Speer CA, Dubey JP. The general biology of Cryptosporidium. In: Fayer R, ed. Cryptosporidium and cryptosporidiosis. Boca Raton, FL: CRC Press, 1997.
9. McDonald AC, Mac Kenzie WR, Addiss DG, et al. Cryptosporidium parvum-specific antibody responses among children residing in Milwaukee during the 1993 waterborne outbreak. J Infect Dis 2001; 183:1373-9.
10. Weber R, Bryan RT, Bishop HS, Wahlquist SP, Sullivan JJ, Juranek DD. Threshold of detection of Cryptosporidium oocysts in human stool specimens: evidence for low sensitivity of current diagnostic methods. J Clin Microbiol 1991; 29:1323-7.
11. Morin CA, Roberts CL, Mshar PA, Addiss DG, Hadler JL. What do physicians know about cryptosporidiosis? A survey of Connecticut physicians. Arch Intern Med 1997; 157:1017-22.
12. Roberts CL, Morin C, Addiss DG, Wahlquist SP, Mshar PA, Hadler JL. Factors influencing Cryptosporidium testing in Connecticut. J Clin Microbiol 1996; 34:2292-3.
13. Leav BA, Mackay M, Ward HD. Cryptosporidium species: new insights and old challenges. Clin Infect Dis 2003; 36:903-8.
14. DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB, Jakubowski W. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med 1995; 332:855-9.
15. Priest JW, Kwon JP, Moss DM, et al. Detection by enzyme immunoassay of serum immunoglobulin G antibodies that recognize specific Cryptosporidium parvum antigens. J Clin Microbiol 1999; 37:1385-92.
16. Priest JW, Kwon JP, Arrowood MJ, Lammie PJ. Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum. Mol Biochem Parasitol 2000; 106:261-71.
17. Priest JW, Li A, Khan M, et al. Enzyme immunoassay detection of antigen-specific immunoglobulin G antibodies in longitudinal serum samples from patients with cryptosporidiosis. Clin Diagn Lab Immunol 2001; 8:415-23.
18. Eisenberg JN, Priest JW, Lammie PJ, Colford JM Jr. The serologic response to Cryptosporidium in HIV-infected persons: implications for epidemiologic research. Emerg Infect Dis 2001; 7:1004-9.
19. Moss DM, Chappell CL, Okhuysen PC, et al. The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans. J Infect Dis 1998; 178:827-33.
20. Frost FJ, Calderon RL, Muller TB, et al. A two-year follow-up survey of antibody to Cryptosporidium in Jackson County, Oregon following an outbreak of waterborne disease. Epidemiol Infect 1998; 121:213-7.
21. Sorvillo F, Beall G, Turner PA, et al. Seasonality and factors associated with cryptosporidiosis among individuals with HIV infection. Epidemiol Infect 1998; 121:197-204.
22. Egorov A, Frost F, Muller T, Naumova E, Tereschenko A, Ford T. Serological evidence of Cryptosporidium infections in a Russian city and evaluation of risk factors for infections. Ann Epidemiol 2004; 14:129-36.
23. Hellard M, Hocking J, Willis J, Dore G, Fairley C. Risk factors leading to Cryptosporidium infection in men who have sex with men. Sex Transm Infect 2003; 79:412-4.
24. Frost FJ, Kunde TR, Muller TB, et al. Serological responses to Cryptosporidium antigens among users of surface- vs. ground-water sources. Epidemiol Infect 2003; 131:1131-8.
25. Frost FJ, Muller T, Calderon RL, Craun GF. A serological survey of college students for antibody to Cryptosporidium before and after the introduction of a new water filtration plant. Epidemiol Infect 2000; 125:87-92.
26. Frost FJ, Muller T, Craun GF, Calderon RL, Roefer PA. Paired city Cryptosporidium serosurvey in the southwest USA. Epidemiol Infect 2001; 126:301-7.
27. Caputo C, Forbes A, Frost F, et al. Determinants of antibodies to Cryptosporidium infection among gay and bisexual men with HIV infection. Epidemiol Infect 1999; 122:291-7.
28. Frost FJ, Tollestrup K, Craun GF, Fairley CK, Sinclair MI, Kunde TR. Protective immunity associated with a strong serological response to a Cryptosporidium-specific antigen group, in HIV-infected individuals. J Infect Dis 2005; 192:618-21.
29. Winkelstein W, Samuel M, Padian N, et al. The San Francisco Men's Health Study. III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-86. Am J Public Health 1987; 77:685-9.
30. Priest JW, Bern C, Xiao L, et al. Longitudinal analysis of Cryptosporidium species-specific immunoglobulin G antibody responses in Peruvian children. Clin Vaccine Immunol 2006; 13:123-31.
31. Selvin S. Statistical analysis of epidemiological data. New York: Oxford University Press, 1991.
32. Elandt-Johnson RC, Johnson NL. Survival models and data analysis. New York: John Wiley & Sons, 1980.
33. Nardi A, Schemper M. Comparing Cox and parametric models in clinical studies. Stat Med 2003; 22:3597-610.